Thank you
This live web event has ended. Thank you for attending.
This live web event has ended. Thank you for attending.
Saskia de Wildt studied Medicine at Maastricht University. She
performed her PhD research at Erasmus University Sophia Children’s Hospital
Rotterdam on Developmental aspects of midazolam metabolism. She next trained in
pediatrics and pediatric intensive care, also in Rotterdam and at the Hospital
of Sick Children in Toronto, while also obtaining the American and Dutch Board
of Clinical Pharmacology certification as clinical pharmacologist. Since May
2016, she is appointed full professor of Clinical Pharmacology, combining this
appointment with clinical care in the Pediatric Intensive Care at Radboud
University in Nijmegen. She has published over 100 peer-review international
papers and received over 3.5 million euros PI research funding. Her research
has been largely supported by ZonMW and EU FP7 grants, which aim to better
understand the impact of age, disease and genetics on drug disposition and to
individualize drug dosing in children, with a focus on pain&sedation and
AKI. She participates in two EU H2020 grants aimed to develop EU-wide
infrastructure to study drugs in children.